China NMPA Drug Inspection - Jilin Jichun Pharmaceutical Co., Ltd. - Diclofenac sodium enteric-coated tablets
China NMPA drug inspection for Jilin Jichun Pharmaceutical Co., Ltd. published April 05, 2017. Drug: Diclofenac sodium enteric-coated tablets. On April 5, 2017, the Fujian Province Drug Quality Announcement (Issue No. 64) was released, detailing findings from sup
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jilin Jichun Pharmaceutical Co., Ltd. published April 05, 2017. Drug: Diclofenac sodium enteric-coated tablets. On April 5, 2017, the Fujian Province Drug Quality Announcement (Issue No. 64) was released, detailing findings from sup
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox